Home › Breast Carcinoma In Situ › Kansas
Breast Carcinoma In Situ clinical trials in Kansas
3 studies for Breast Carcinoma In Situ are looking for participants at sites in Kansas.
Cities in Kansas
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2Healthy volunteers welcome
Ages 45 to 74 · Women · Updated Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2
Ages 18 to 55 · Women · Updated Jul 27, 2026 · NCT06184750Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- University of Kansas Cancer Center, Kansas City
RecruitingPhase 2
Ages 35 and older · Women · Updated Jul 7, 2026 · NCT05941520From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.